We identified that SLC35A2 expression is negatively associated with the levels of CD8+ T cell infiltration, NK cell infiltration, B cells, and CD4+ T cells in various cancers, indicating that higher SLC35A2 expression may be correlated to fewer lymphocyte cells infiltration and lead to poor prognosis. Here, SLC35A2 is linked to cancer.